Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

ABSTRACT
SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. We systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in a large cohort of unexposed individuals as well as exposed family members and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative family members and individuals with a history of asymptomatic or mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
One sentence summary SARS-CoV-2 induces robust memory T cell responses in antibody-seronegative and antibody-seropositive individuals with asymptomatic or mild COVID-19.
Subject Area
- Biochemistry (8784)
- Bioengineering (6490)
- Bioinformatics (23377)
- Biophysics (11761)
- Cancer Biology (9164)
- Cell Biology (13267)
- Clinical Trials (138)
- Developmental Biology (7420)
- Ecology (11380)
- Epidemiology (2066)
- Evolutionary Biology (15110)
- Genetics (10408)
- Genomics (14017)
- Immunology (9133)
- Microbiology (22086)
- Molecular Biology (8792)
- Neuroscience (47417)
- Paleontology (350)
- Pathology (1421)
- Pharmacology and Toxicology (2483)
- Physiology (3710)
- Plant Biology (8060)
- Synthetic Biology (2213)
- Systems Biology (6019)
- Zoology (1251)